Return to Press Releases
| Company Contact: |
Investor Contacts: |
| Pet DRx Corporation |
Lippert/Heilshorn & Associates,
Inc. |
| Gregory J. Eisenhauer CFA, EVP & CFO |
Bruce Voss (bvoss@lhai.com) |
| geisenhauer@petdrx.com |
Don Markley (dmarkley@lhai.com) |
|
(408) 236-7428 |
(310) 691-7100 – http://www.lhai.com |
PET DRx TO BEGIN TRADING ON NASDAQ CAPITAL MARKET
Brentwood, Tenn. — May 28, 2008 — Pet DRx Corporation (OTCBB:
PDXC, PDXCW, PDXCU) today announced that its common stock,
warrants and units will commence trading on the Nasdaq Capital
Market under the symbols “VETS,” “VETSW,” and “VETSU”
respectively, when the market opens on May 29, 2008.
Pet DRx stock, warrants and units formerly traded on the OTC
Bulletin Board under the symbols “PDXC,” “PDXCW,” and “PDXCU,”
respectively.
“We are excited to have been approved for listing on the Nasdaq
Capital Market. The listing on Nasdaq is an important milestone
for Pet DRx, and includes a number of benefits, such as
increased visibility in the financial community, greater
liquidity for our stock and a larger potential investor base,”
said Robert Wallace, Chief Executive Officer of PetDRx.
About Pet DRx
Pet DRx Corporation, headquartered in Brentwood, Tennessee,
provides veterinary primary care and specialized services to
companion animals through a network of fully-owned veterinary
hospitals. The Company currently owns and operates 26 leading
veterinary hospitals in the state of California, which it has
organized into unique, regional “hub and spoke” networks. Pet
DRx provides a full range of general medical treatments for
companion animals, including (i) preventive care, such as
examinations, vaccinations, spaying/neutering and dental care
and (ii) a broad range of specialized diagnostic and medical
services, such as internal medicine, surgery, cardiology,
ophthalmology, dermatology, oncology, neurology, x-ray,
ultrasound and other services.
SAFE HARBOR STATEMENT
Certain statements and information included in this press
release, including statements as to the expected visibility and
liquidity of the Company’s common shares, constitute
“forward-looking statements” within the meaning of the Federal
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are subject to risks and
uncertainties that may cause actual results to differ
materially, including, but not limited to, the ability of the
Company to successfully acquire, integrate and operate
veterinary hospitals and clinics, requirements or changes
affecting the businesses in which the Company is engaged,
veterinary services trends, including factors affecting supply
and demand, dependence on acquisitions for growth, labor and
personnel relations, changing interpretations of generally
accepted accounting principles and other risks detailed from
time to time in the Company’s SEC reports, including its Current
Report on Form 8-K, as amended, filed on April 4, 2008 and its
Registration Statement on Form S-4, as amended, filed on
November 8, 2007. These forward-looking statements speak only as
of the date hereof. The Company disclaims any intention or
obligation to update or revise any forward-looking statements.
# # # #
|
